Abstract
Neuropsychological assessment has a distinct role in the detection and monitoring of cognitive and functional changes associated with dementing illness. Molecular, structural and functional neuroimaging studies have advanced our understanding of the anatomy and physiology underlying neurodegenerative disease; however, the overlap in pathological features of different dementia-associated diseases limits the information that can be obtained by these methods. Incorporation of information obtained from multiple sources can help to increase diagnostic and prognostic accuracy. Neuropsychological test findings provide unique value as biomarkers of dementia, as differentiators of disease topography and in the estimation of disease risk and trajectory. However, psychometric test properties—such as construct validity, stability and the use of appropriate norms—must be understood, because they influence both the application of neuropsychological tests and the interpretation of their results. Finally, measurement of cognitive strengths and weaknesses in patients at risk of dementia can be helpful to predict changes in functional abilities, design appropriate and effective interventions, and assist family and health-care providers in the planning of the patient's future care needs. This Review describes the key characteristics of neuropsychological testing in the assessment of patients at risk of dementia.
Key Points
-
Neuropsychological parameters serve as biomarkers for and potent predictors of the development of dementia
-
Serial use of neuropsychological tests can dynamically capture the effects of various influences on disease trajectory
-
Deficits on neuropsychological measures are proxies for functional deficiencies in patients with possible dementia
-
Neuropsychological test results can be used to identify targets for intervention; for example, intact procedural memory might be used to compensate for deficient declarative memory
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schoonenboom, N. S. et al. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease. Neurobiol. Aging 29, 669–675 (2008).
Klunk, W. E. et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann. Neurol. 55, 306–319 (2004).
Clark, C. M. et al. Cerebrospinal fluid tau and β-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch. Neurol. 60, 1696–1702 (2003).
Shaw, L. M. et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann. Neurol. 65, 403–413 (2009).
Jack, C. R. Jr et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119–128 (2010).
Smith, G. E. et al. Time course of diagnostic features of Lewy body disease. Neurology 72 (Suppl. 3), A246 (2009).
Jack, C. R. Jr et al. Introduction to the recommendations from the National Institute on Aging and Alzheimer's Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 7, 257–262 (2011).
Greenaway, M. C., Smith, G. E., Tangalos, E. G., Geda, Y. E. & Ivnik, R. J. Mayo older Americans normative studies: factor analysis of an expanded neuropsychological battery. Clin. Neuropsychol. 23, 7–20 (2009).
Pedraza, O. et al. Mayo's older African American normative studies: confirmatory factor analysis of a core battery. J. Int. Neuropsychol. Soc. 11, 184–191 (2005).
Smith, G. E. et al. The Mayo Cognitive Factor Scales (MCFS): derivation of a short battery and norms for factor scores. Neuropsychology 9, 194–202 (1994).
Squire, L. R. Memory and brain systems: 1969–2009 J. Neurosci. 29, 12711–12716 (2009).
Smith, G. E. Is mild cognitive impairment bridging the gap between normal aging and Alzheimer's disease? J. Neural Transm. Suppl. 62, 97–104 (2002).
Attix, D. K. et al. The prediction of change: normative neuropsychological trajectories. Clin. Neuropsychol. 23, 21–38 (2009).
Stein, J., Luppa, M., Brahler, E., Konig, H. H. & Riedel-Heller, S. G. The assessment of changes in cognitive functioning: reliable change indices for neuropsychological instruments in the elderly—a systematic review. Dement. Geriatr. Cogn. Disord. 29, 275–286 (2010).
Busch, R. M., Chelune, G. J. & Suchy, Y. in Geriatric Neuropsychology: Assessment and Intervention (eds Attix, D. K. & Welsh-Bohmer, K. A.) 133–157 (Guilford, New York, 2006).
Ivnik, R. J. et al. Testing normal older people three or four times at 1- to 2-year intervals: defining normal variance. Neuropsychology 13, 121–127 (1999).
O'Connell, M. E. & Tuokko, H. Age corrections and dementia classification accuracy. Arch. Clin. Neuropsychol. 25, 126–138 (2010).
Sliwinski, M. J., Hofer, S. M., Hall, C., Buschke, H. & Lipton, R. D. in Mild Cognitive Impairment (ed. Petersen, R.) 89–104 (Oxford University Press, New York, 2003).
Sackett, D. L., Haynes, R. B., Guyatt, G. H. & Tugwell, P. Clinical Epidemiology: A Basic Science for Clinical Medicine (Lippincott Williams & Wilkins, New York, 1991).
Sackett, D. L., Straus, S. E., Richardson, W. S., Rosenberg, W. & Haynes, R. B. Evidence-Based Medicine: How to Practice and Teach EBM (Churchill Livingstone, New York, 2000).
Smith, G. E. & Ivnik, R. J. in Mild Cognitive Impairment (ed. Petersen, R.) 63–88 (Oxford University Press, New York, 2003).
Mitrushina, M., Boone, K. B., Razani, J. & D'Elia, L. F. Handbook of Normative Data for Neuropsychological Assessment (Oxford University Press, New York, 2005).
Strauss, E., Sherman, E. M. S. & Spreen, O. (eds) A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (Oxford University Press, New York, 2006).
Heaton, R. K., Miller, S. W., Taylor, M. J. & Grant, I (eds) Revised Comprehensive Norms for an Expanded Halstead–Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults—Professional Manual (Psychological Assessment Resources, Lutz, 2004).
Ivnik, R. J., Malec, J. F., Smith, G. E., Tangalos, E. G. & Petersen, R. C. Neuropsychological tests' norms above age 55: COWAT, BNT, MAE Token, WRAT-R. Reading, AMNART, STROOP, TMT, and JLO. Clin. Neuropsychol. 10, 262–278 (1996).
Pedraza, O. et al. Robust and expanded norms for the Dementia Rating Scale. Arch. Clin. Neuropsychol. 25, 347–358 (2010).
Lucas, J. A. et al. Mayo's older Americans normative studies: category fluency norms. J. Clin. Exp. Neuropsychol. 20, 194–200 (1998).
Ivnik, R. J. et al. Free and cued selective reminding test: MOANS norms. J. Clin. Exp. Neuropsychol. 19, 676–691 (1997).
Byrd, D. A. & Manly, J. J. in Geriatric Neuropsychology: Practice Essentials (eds Bush, S. S. & Martin, T. A) 116–139 (Taylor & Francis, New York, 2005).
Romero, H. R. et al. Challenges in the neuropsychological assessment of ethnic minorities: summit proceedings. Clin. Neuropsychol. 23, 761–779 (2009).
Farias, S. T., Mungas, D., Reed, B., Haan, M. N. & Jagust, W. J. Everyday functioning in relation to cognitive functioning and neuroimaging in community-dwelling Hispanic and non-Hispanic older adults. J. Int. Neuropsychol. Soc. 10, 342–354 (2004).
Shuttleworth-Edwards, A. B. et al. Cross-cultural effects on IQ test performance: a review and preliminary normative indications on WAIS-III test performance. J. Clin. Exp. Neuropsychol. 26, 903–920 (2004).
Boone, K. B., Victor, T. L., Wen, J., Razani, J. & Ponton, M. The association between neuropsychological scores and ethnicity, language, and acculturation variables in a large patient population. Arch. Clin. Neuropsychol. 22, 355–365 (2007).
Campbell, A. L. Jr et al. Caveats in the neuropsychological assessment of African Americans. J. Natl Med. Assoc. 94, 591–601 (2002).
Manly, J. J., Jacobs, D. M., Touradji, P., Small, S. A. & Stern, Y. Reading level attenuates differences in neuropsychological test performance between African American and white elders. J. Int. Neuropsychol. Soc. 8, 341–348 (2002).
Patton, D. E. et al. Performance of cognitively normal African Americans on the RBANS in community dwelling older adults. Clin. Neuropsychol. 17, 515–530 (2003).
Manly, J. J. et al. Cognitive test performance among nondemented elderly African Americans and whites. Neurology 50, 1238–1245 (1998).
Lichtenberg, P. A., Manning, C. A., Vangel, C. A. & Ross, T. P. Normative and ecological validity data in older urban medical patients: a program of neuropsychological research. Adv. Med. Psychotherapy 8, 121–136 (1995).
Lucas, J. A. et al. Mayo's older African Americans normative studies: norms for Boston Naming Test, Controlled Oral Word Association, Category Fluency, Animal Naming, Token Test, WRAT-3 Reading, Trail Making Test, Stroop Test, and Judgment of Line Orientation. Clin. Neuropsychol. 19, 243–269 (2005).
Rilling, L. M. et al. Mayo's older African American normative studies: norms for the Mattis Dementia Rating Scale. Clin. Neuropsychol. 19, 229–242 (2005).
Ferman, T. J. et al. Mayo's older African American normative studies: auditory verbal learning test norms for African American elders. Clin. Neuropsychol. 19, 214–228 (2005).
Lucas, J. A. et al. Mayo's older African Americans normative studies: WMS-R norms for African American elders. Clin. Neuropsychol. 19, 189–213 (2005).
Ponton, M. O. et al. Normative data stratified by age and education for the Neuropsychological Screening Battery for Hispanics (NeSBHIS): initial report. J. Int. Neuropsychol. Soc. 2, 96–104 (1996).
Ostrosky-Solis, F. et al. NEUROPSI attention and memory: a neuropsychological test battery in Spanish with norms by age and educational level. Appl. Neuropsychol. 14, 156–170 (2007).
Mungas, D., Widaman, K. F., Reed, B. R. & Tomaszewski Farias, S. Measurement invariance of neuropsychological tests in diverse older persons. Neuropsychology 25, 260–269 (2011).
Siedlecki, K. L. et al. Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology 24, 402–411 (2010).
Smith, G. E., Ivnik, R. J. & Lucas, J. in Textbook of Clinical Neuropsychology (eds Morgan, J. & Ricker, J.) 38–57 (Taylor & Francis, New York, 2008).
Heaton, R. K., Ryan, L. & Grant, I. in Neuropsychological Assessment of Neuropsychiatric and Neuromedical Disorders (eds Grant, I. & Adams, K. M.) 127–155 (Oxford University Press, New York, 2009).
Nauert, R. Revised Psychiatric Diagnosis Manual, DSM-V. Psych Central [online], (2011).
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001).
Lezak, M. D., Howieson, D. B. & Loring, D. W. in Neuropsychological Assessment 100–132 (Oxford University Press, New York, 2004).
Raz, N. & Rodrigue, K. M. Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci. Biobehav. Rev. 30, 730–748 (2006).
Hedden, T. & Gabrieli, J. D. Insights into the ageing mind: a view from cognitive neuroscience. Nat. Rev. Neurosci. 5, 87–96 (2004).
Eyler, L. T., Sherzai, A., Kaup, A. R. & Jeste, D. V. A review of functional brain imaging correlates of successful cognitive aging. Biol. Psychiatry 70, 115–122 (2011).
Kaup, A. R., Mirzakhanian, H., Jeste, D. V. & Eyler, L. T. A review of the brain structure correlates of successful cognitive aging. J. Neuropsychiatry Clin. Neurosci. 23, 6–15 (2011).
Chapman, R. M. et al. Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses. J. Clin. Exp. Neuropsychol. 32, 793–808 (2010).
Powell, M. R. et al. Cognitive measures predict pathologic Alzheimer disease. Arch. Neurol. 63, 865–868 (2006).
Filoteo, J. V. et al. Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia. J. Clin. Exp. Neuropsychol. 31, 823–834 (2009).
Murray, R. et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 68, 1274–1283 (2007).
Galton, C. J., Patterson, K., Xuereb, J. H. & Hodges, J. R. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123, 484–498 (2000).
Mitchell, T. W. et al. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann. Neurol. 51, 182–189 (2002).
Rascovsky, K., Salmon, D. P., Hansen, L. A., Thal, L. J. & Galasko, D. Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology 21, 20–30 (2007).
Kraybill, M. L. et al. Cognitive differences in dementia patients with autopsy-verified, AD, Lewy body pathology, or both. Neurology 64, 2069–2073 (2005).
van Harten, A. C. et al. Review: tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin. Chem. Lab. Med. 49, 353–366 (2011).
Whitwell, J. L. et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain 132, 2932–2946 (2009).
Hu, W. T. et al. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch. Neurol. 66, 1359–1364 (2009).
Forman, M. S. et al. Frontotemporal dementia: clinicopathological correlations. Ann. Neurol. 59, 952–962 (2006).
Miller, B. L. in The Behavioral Neurology of Dementia (eds Miller, B. L. & Boeve, B. F) 1–6 (Cambridge University Press, New York, 2009).
Grossman, M. et al. Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. Arch. Neurol. 64, 1601–1609 (2007).
Gorno-Tempini, M. L. et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006–1014 (2011).
Josephs, K. A. et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129, 1385–1398 (2006).
Ferman, T. J. et al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin. Neuropsychol. 20, 623–636 (2006).
Boeve, B. F. in The Behavioral Neurology of Dementia (eds Miller, B. L. & Boeve, B. F) 197–212 (Cambridge University Press, New York, 2009).
Marui, W., Iseki, E., Kato, M., Akatsu, H. & Kosaka, K. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease. Acta Neuropathol. 108, 121–128 (2004).
Reed, B. R. et al. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain 130, 731–739 (2007).
Desmond, D. W. The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J. Neurol. Sci. 226, 3–7 (2004).
Graham, N. L., Emery, T. & Hodges, J. R. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J. Neurol. Neurosurg. Psychiatry 75, 61–71 (2004).
Duke, L. M. & Kaszniak, A. W. Executive control functions in degenerative dementias: a comparative review. Neuropsychol. Rev. 10, 75–99 (2000).
Carew, T. G., Lamar, M., Cloud, B. S., Grossman, M. & Libon, D. J. Impairment in category fluency in ischemic vascular dementia. Neuropsychology 11, 400–412 (1997).
Libon, D. J. et al. Dementia associated with periventricular and deep white matter alterations: a subtype of subcortical dementia. Arch. Clin. Neuropsychol. 12, 239–250 (1997).
Lamar, M., Catani, M., Price, C. C., Heilman, K. M. & Libon, D. J. The impact of region-specific leukoaraiosis on working memory deficits in dementia. Neuropsychologia 46, 2597–2601 (2008).
Lamar, M., Price, C. C., Davis, K. L., Kaplan, E. & Libon, D. J. Capacity to maintain mental set in dementia. Neuropsychologia 40, 435–445 (2002).
Cosentino, S., Jefferson, A., Chute, D. L., Kaplan, E. & Libon, D. J. Clock drawing errors in dementia: neuropsychological and neuroanatomical considerations. Cogn. Behav. Neurol. 17, 74–84 (2004).
Price, C. C., Jefferson, A. L., Merino, J. G., Heilman, K. M. & Libon, D. J. Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology 65, 376–382 (2005).
Leber, P. Guidelines for the clinical evaluation of antidementia drugs. First draft [online], (1990).
Ewers, M. et al. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol. Aging 34, 430–442 (2011).
Landau, S. M. et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75, 230–238 (2010).
Bäckman, L., Jones, S., Berger, A. K., Laukka, E. J. & Small, B. J. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 19, 520–531 (2005).
Bozoki, A., Giordani, B., Heidebrink, J. L., Berent, S. & Foster, N. L. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch. Neurol. 58, 411–416 (2001).
Lopez, O. L. et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch. Neurol. 60, 1385–1389 (2003).
Molinuevo, J. L. et al. Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates. Arch. Gerontol. Geriatr. 52, 190–196 (2011).
Tabert, M. H. et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch. Gen. Psychiatry 63, 916–924 (2006).
Chen, P. et al. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 55, 1847–1853 (2000).
DeCarli, C. et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 63, 220–227 (2004).
Devanand, D. P. et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 68, 828–836 (2007).
Elias, M. F. et al. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort. Arch. Neurol. 57, 808–813 (2000).
Rozzini, L. et al. Conversion of amnestic mild cognitive impairment to dementia of Alzheimer type is independent to memory deterioration. Int. J. Geriatr. Psychiatry 22, 1217–1222 (2007).
Tierney, M. C., Moineddin, R. & McDowell, I. Prediction of all-cause dementia using neuropsychological tests within 10 and 5 years of diagnosis in a community-based sample. J. Alzheimer's Dis. 22, 1231–1240 (2010).
Locke, D. E. et al. Age, family history, and memory and future risk for cognitive impairment. J. Clin. Exp. Neuropsychol. 31, 111–116 (2009).
Stern, Y. Cognitive reserve. Neuropsychologia 47, 2015–2028 (2009).
Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183–194 (2004).
Twamley, E. W., Ropacki, S. A. & Bondi, M. W. Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J. Int. Neuropsychol. Soc. 12, 707–735 (2006).
Smith, G. E. et al. A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms? Neurology 69, 133–139 (2007).
Grady, C. L. et al. Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J. Neurosci. 23, 986–993 (2003).
Yetkin, F. Z., Rosenberg, R. N., Weiner, M. F., Purdy, P. D. & Cullum, C. M. FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease. Eur. Radiol. 16, 193–206 (2006).
Fields, J. A. et al. Utility of the DRS for predicting problems in day-to-day functioning. Clin. Neuropsychol. 24, 1167–1180 (2010).
Ganguli, M. et al. Cognitive test performance predicts change in functional status at the population level: the MYHAT Project. J. Int. Neuropsychol. Soc. 16, 761–770 (2010).
Kim, K. R. et al. Characteristic profiles of instrumental activities of daily living in different subtypes of mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 27, 278–285 (2009).
Pereira, F. S. et al. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J. Int. Neuropsychol. Soc. 16, 297–305 (2010).
Schmitter-Edgecombe, M., Woo, E. & Greeley, D. R. Characterizing multiple memory deficits and their relation to everyday functioning in individuals with mild cognitive impairment. Neuropsychology 23, 168–177 (2009).
Tomaszewski Farias, S. et al. Longitudinal changes in memory and executive functioning are associated with longitudinal change in instrumental activities of daily living in older adults. Clin. Neuropsychol. 23, 446–461 (2009).
Boyle, P. A. et al. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am. J. Geriatr. Psychiatry 11, 214–221 (2003).
O'Bryant, S. E. et al. Executive functioning mediates the link between other neuropsychological domains and daily functioning: a Project FRONTIER study. Int. Psychogeriatr. 23, 107–113 (2011).
Smith, G. E., O'Brien, P. C., Ivnik, R. J., Kokmen, E. & Tangalos, E. G. Prospective analysis of risk factors for nursing home placement of dementia patients. Neurology 57, 1467–1473 (2001).
Lemsky, C. M., Smith, G., Malec, J. F. & Ivnik, R. J. Identifying risk for functional impairment using cognitive measures: an application of CART modeling. Neuropsychology 10, 368–375 (1996).
Belleville, S. et al. Improvement of episodic memory in persons with mild cognitive impairment and healthy older adults: evidence from a cognitive intervention program. Dement. Geriatr. Cogn. Disord. 22, 486–499 (2006).
Cipriani, G., Bianchetti, A. & Trabucchi, M. Outcomes of a computer-based cognitive rehabilitation program on Alzheimer's disease patients compared with those on patients affected by mild cognitive impairment. Arch. Gerontol. Geriatr. 43, 327–335 (2006).
Rapp, S., Brenes, G. & Marsh, A. P. Memory enhancement training for older adults with mild cognitive impairment: a preliminary study. Aging Ment. Health 6, 5–11 (2002).
Talassi, E. et al. Effectiveness of a cognitive rehabilitation program in mild dementia (MD) and mild cognitive impairment (MCI): a case control study. Arch. Gerontol. Geriatr. 44 (Suppl. 1), 391–399 (2007).
Jean, L., Bergeron, M. E., Thivierge, S. & Simard, M. Cognitive intervention programs for individuals with mild cognitive impairment: systematic review of the literature. Am. J. Geriatr. Psychiatry 18, 281–296 (2010).
Acknowledgements
This work was supported by NIH grants 1K12HD065987, RO1 AG15866, P50 AG16574 and R01 NR12419. We wish to acknowledge our colleagues affiliated with the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation.
Author information
Authors and Affiliations
Contributions
J. A. Fields researched data for the article. G. E. Smith and J. A. Fields organized and wrote the article. T. J. Ferman and B. F. Boeve contributed to discussions of the content and to review and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Fields, J., Ferman, T., Boeve, B. et al. Neuropsychological assessment of patients with dementing illness. Nat Rev Neurol 7, 677–687 (2011). https://doi.org/10.1038/nrneurol.2011.173
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2011.173
This article is cited by
-
Diagnostic Accuracy of Memory Measures in Alzheimer’s Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis
Neuropsychology Review (2017)
-
Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias?
Alzheimer's Research & Therapy (2014)